Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Running, not enrolling · Not applicable

Conditions studied: Preeclampsia Postpartum

In brief

This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).

Key facts

Study ID

NCT05534932

Run by

University of Chicago

People needed

20

Starts

2022-10-27

Expected to finish

2026-11-01

Last updated by the study team

2025-11-10

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Adults between 18 and 45 years of age
• African American
• >120/80 BP at the time of their 6-month visit in the PARENT study
• Diagnosed with preeclampsia
• Initially presented to University of Chicago Medical Center (UCMC) for a Singleton Gestation Delivery
• Completed the 6 month visit in the PARENT study

You may not qualify if…

• Those who cannot provide consent
• patients with preexisting cardiomyopathy, ischemic or valvular heart disease, pulmonary disease, diabetes mellitus, chronic kidney disease, multiple gestations,
• Unable to operate the RPM tablet device

Where it is running

• University of Chicago Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.